CaltechAUTHORS
  A Caltech Library Service

Dose-response relations for unnatural amino acids at the agonist binding site of the nicotinic acetylcholine receptor: tests with novel side chains and with several agonists

Kearney, Patrick C. and Nowak, Mark W. and Zhong, Wenge and Silverman, Scott K. and Lester, Henry A. and Dougherty, Dennis A. (1996) Dose-response relations for unnatural amino acids at the agonist binding site of the nicotinic acetylcholine receptor: tests with novel side chains and with several agonists. Molecular Pharmacology, 50 (5). pp. 1401-1412. ISSN 0026-895X. https://resolver.caltech.edu/CaltechAUTHORS:20200626-123657699

Full text is not posted in this repository. Consult Related URLs below.

Use this Persistent URL to link to this item: https://resolver.caltech.edu/CaltechAUTHORS:20200626-123657699

Abstract

Structure-function relations in the nicotinic acetylcholine receptor are probed using a recently developed method based on chemical synthesis of nonsense suppressor tRNAs with unnatural amino acid residues, site-directed incorporation at nonsense codons in Xenopus laevis oocytes, and electrophysiological measurements. A broad range of unnatural amino acids, as many as 14 at a given site, are incorporated at three sites, alpha 93, alpha 190, and alpha 198, all of which are tyrosine in the wild-type receptor and are thought to contribute to the agonist binding site. Confirming and expanding upon earlier studies using conventional mutagenesis, the three tyrosines are shown to be in substantially different structural microenvironments. In particular, a crucial role is established for the hydroxyl group of alpha Tyr93, whereas a variety of substituents are functional at the analogous position of alpha Tyr198. Interestingly, consideration of three different agonists (acetylcholine, nicotine, and tetramethylammonium) does not discriminate between these two best-characterized binding site residues. In addition, double-mutation studies establish the independent effects of mutations at the pore region (second transmembrane region) and at the agonist binding site, and this observation leads to a novel strategy for adjusting EC₅₀ values. These results establish the broad generality and great potential of the unnatural amino acid methodology for illuminating subtle structural distinctions in neuroreceptors and related integral membrane proteins.


Item Type:Article
Related URLs:
URLURL TypeDescription
http://molpharm.aspetjournals.org/content/50/5/1401.longPublisherArticle
ORCID:
AuthorORCID
Silverman, Scott K.0000-0001-8166-3460
Lester, Henry A.0000-0002-5470-5255
Dougherty, Dennis A.0000-0003-1464-2461
Additional Information:© 1996 by the American Society for Pharmacology and Experimental Therapeutics. Received June 10, 1996; Accepted August 3, 1996. This work was supported by the National Institutes of Health (Grants NS34407 and NS11756) and by the Beckman Institute at Caltech. We thank Dr. Margaret E. Saks and Dr. Jeffrey R. Sampson for providing T7 polymerase and helpful advice.
Funders:
Funding AgencyGrant Number
NIHNS34407
NIHNS11756
Caltech Beckman InstituteUNSPECIFIED
Issue or Number:5
Record Number:CaltechAUTHORS:20200626-123657699
Persistent URL:https://resolver.caltech.edu/CaltechAUTHORS:20200626-123657699
Official Citation:Dose-response relations for unnatural amino acids at the agonist binding site of the nicotinic acetylcholine receptor: tests with novel side chains and with several agonists. P C Kearney, M W Nowak, W Zhong, S K Silverman, H A Lester and D A Dougherty Molecular Pharmacology November 1, 1996, 50 (5) 1401-1412
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:104083
Collection:CaltechAUTHORS
Deposited By: George Porter
Deposited On:26 Jun 2020 22:18
Last Modified:26 Jun 2020 22:18

Repository Staff Only: item control page